Tag: Global Health

Innovative financing into hepatitis B and C prevention and treatment in low and middle income countries
Innovative sources of financing to help scale up prevention and treatment of viral hepatitis in low and middle-income countries
Health technology assessment
Value of immunization
Mental and neurological disorders addressing a global health priority
2015 IFPMA pharma by numbers - Video
IFPMA 2015 pharma by numbers
IFPMA facts & figures 2015
The Exciting Journey from Flu Virus to Vaccine
Evidence-informed benefits design in the context of universal health coverage, proposed policy principles
R&D pipeline for malaria
Pharmaceutical industry and global health
Pharma R&D and global health - IFPMA facts & figures 2014
Pharmaceutical R&D Projects to Prevent and Control Neglected Conditions
Technology transfer: a collaborative approach to improve global health
Innovation for a healthier world: How the research-based vaccine manufacturers are contributing to the Decade of vaccines action plan
Mr Masafumi Nogimori, speach at the closing session
Dr Stefan Oschmann, inaugural speech – transcript
Hepatitis C Infographic
WHA 67 agenda item 11.3, Framework of engagement with non-State actors
Agenda item 5, "WHO Reform"
WHA 66 agenda item 13.2 on draft action plan for the prevention and control
WHA 66, Item 16.2, Neglected tropical diseases
Health by the numbers: results of the 2011 IFPMA wellness survey
R&D-based pharmaceutical industry and International Federation of Red Cross and Red Crescent Societies join forces to prevent NCDs
Introducing the study "Falsified medicines and the global public's health"
Introduction - Mario Ottiglio, director, public affairs and global health policy, IFPMA
Fake medicines - imminent risks to global health
Fake medicines - Imminent risks to global health: remarks by Jamil Chade
IFPMA highlights benefits of incremental innovation for global health

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Clinical Trials Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 COVID-19 vaccines Dementia Developing World Diabetes Economic footprint Epidemics Ethics Event Highlights Fake Medicines Fakes Falsified Medicines Fight the Fakes Flu Global Health global health security harmonization Health Health Partnerships HIV/AIDS IFPMA IFPMA Assembly IFPMA Statement Immunization Incremental Innovation Influenza Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics partnership Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers